Syngene International accepts General Counsel resignation

Syngene International has accepted the resignation of Surender Sharma as General Counsel and a member of its Executive Committee. The resignation is effective from the close of business hours on July 15, 2026, following a mutual decision between the executive and the company. Sharma is departing to pursue other career opportunities, marking a change in the company's senior management personnel structure.

The disclosure was made to the stock exchanges pursuant to Regulation 30 read with Para A (7) of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the departure is by mutual consent and that all necessary procedural details have been submitted to the exchanges.

The table below summarizes the key details regarding the change in senior management personnel:

S. No.	Particulars	Details
1.	Reason for change	Leaving by mutual consent to pursue other career opportunities
2.	Date of cessation	Effective from close of business hours on July 15, 2026
3.	Brief profile	Not Applicable
4.	Disclosure of relationships	Not Applicable

Chethan Yogesh, Company Secretary & Compliance Officer of Syngene International, signed the regulatory filing on July 14, 2026. The information regarding this change in senior management has been made available on the company's official website.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.21%	-2.51%	-8.53%	-33.43%	-33.01%	-28.16%

Kiran Mazumdar-Shaw, promoter of syngene international and founder of Biocon, has publicly stated her confidence that the contract research and manufacturing services company will see a turnaround by the next fiscal year. The remarks, reported by NDTV Profit, reflect a forward-looking stance from one of the company's key stakeholders on the business outlook.

Promoter's Statement on Business Outlook

Mazumdar-Shaw's comments underline a degree of conviction in Syngene International's ability to recover and improve its performance in the coming fiscal period. As a prominent promoter, her public expression of confidence is noteworthy for investors and market observers tracking the company's progress.

About Syngene International

Syngene International is a leading contract research and manufacturing organisation that provides integrated scientific services to the global pharmaceutical, biotechnology, and nutrition industries. The company operates across discovery, development, and manufacturing services, serving a diverse international client base.

Note: The source material for this article contains limited financial or operational data. The article reflects only the information explicitly available in the provided source.